You Searched For "biotechnology" and got 17 results
Sort By:
1 min read
Biotechnology Breakthroughs
Biotechnology Breakthroughs
2 mins read
FII's bullish on financial services and telecom segment as per June 2024 NSDL data
The Indian equity market witnessed a significant boost in the latter half of June 2024, with FII re…
ANI
1 min read
A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year
The Tema Cardiovascular and Metabolic ETF holds positions in around 20 companies, including Novo No…
Jennifer Sor
1 min read
Nautilus Biotechnology soars 65% after Amazon reveals a $15 million stake in the small-cap company
Nautilus is developing a platform that works to measure and identify the complexities of proteins, …
Matthew Fox
1 min read
Vir Biotechnology spikes 36% after it says its COVID-19 treatment reduced hospitalizations and deaths in high-risk patients
The company said it will seek emergency use authorization for the drug in the US and in other count…
Isabelle Lee
1 min read
Biogen plummets 32% after its Alzheimer's therapy fails to win support from FDA advisory committee
The committee voted 8-1 that data from a Biogen study evaluating patients with mild Alzheimer's was…
Matthew Fox
1 min read
MyoKardia soars 59% after Bristol-Myers agrees to acquire it for $13 billion in cash
MyoKardia's mavacamten candidate is expected to be submitted to the FDA for approval in the first q…
Matthew Fox
2 mins read
Immunomedics soars 106% after Gilead agrees to acquire the cancer-drug company for $21 billion
Gilead expects the deal to immediately bolster its revenue growth, and to be neutral to accretive t…
Matthew Fox
2 mins read
Amarin plummets 31% after appeal hearing related to its heart drug is 'incrementally negative,' analyst says to not buy shares
The hearing was "incrementally negative" for Amarin and gave no confidence that Amarin will prevail…
Matthew Fox
4 mins read
I tried electrocuting my pelvis to help my severe period cramps, and found its excellent short-term relief wasn't enough for me to pay $200
Every month, my cramps are so painful I've had to cancel social plans. PowerDot, a wellness device,…
Allana Akhtar
2 mins read
Eli Lilly soars 15% after its breast cancer drug shows efficacy where a treatment from Pfizer failed
Verzenio was first approved in 2017 for treating certain forms of advanced breast cancer, and its r…
Matthew Fox
2 mins read
Gilead slides 4% after COVID-19 drug shows limited benefit in moderately ill patients
Patients who received remdesivir for five days were 65% more likely to show signs of recovery than …
Saloni Sardana
2 mins read
Moderna climbs 5% as Fauci calls its early COVID-19 vaccine data 'quite promising'
"Having looked at the data my self, it is really quite promising," Fauci said about Moderna's COVID…
Matthew Fox
2 mins read
A Harvard medical professor is now a billionaire after his early stake in Moderna soared 17,000%
Timothy Springer invested $5 million in the biotech company early on, and his stake has since swell…
Ben Winck
2 mins read
These are the top 10 holdings of the AI-driven investment fund powered by Watson that has been crushing the market this year
The AIEQ ETF is fully invested in the stock market, which according to DataTrek Research means it e…
Matthew Fox
2 mins read
Inside Sana Biotechnology's plans to go public
These are Business Insider's biggest healthcare stories for January 14.
Lydia Ramsey Pflanzer
4 mins read
5 kinds of technology that the US's top spy catchers say rivals are gaining an edge in
That tech "may determine whether America remains the world's leading superpower or is eclipsed by s…